Skip to Main Content

Paper Details

Seroprevalence of antibodies to SARS-CoV-2 in healthcare workers: a cross-sectional study.
BMJ Open
24
2021
COVID-19, COVID-19 illness, COVID-19 infection, PARTICIPANTS, SARS, SARS-CoV, SARS-CoV-2, anosmia, fever, healthcare workers, myalgias, participant, patient
Author NameAffiliation
Christine M AlbertCedars-Sinai Medical Center
Christine M AlbertSmidt Heart Institute, Cedars-Sinai Medical Center
Dermot P B McGovernF. Widjaja Foundation Inflammatory Bowel and Immunobiology Research Institute, Cedars-Sinai Medical Center
Dermot P B McGovernF. Widjaja Foundation Inflammatory Bowel and Immunobiology Research Institute, Cedars-Sinai Medical Center
Jennifer E Van EykCedars-Sinai Medical Center
Jennifer E Van EykCedars-Sinai Medical Center
Jennifer E Van EykAdvanced Clinical Biosystems Institute, Cedars-Sinai Medical Center
Jennifer E Van EykCedars-Sinai Medical Center
Jennifer E Van EykAdvanced Clinical Biosystems Institute, Cedars-Sinai Medical Center
Jennifer E Van EykCedars-Sinai Medical Center
Jonathan BraunCedars-Sinai Medical Center
Jonathan BraunCedars-Sinai Medical Center
Susan ChengCedars-Sinai Medical Center
Susan ChengSmidt Heart Institute, Cedars-Sinai Medical Center
Susan ChengCedars-Sinai Medical Center
  • 1 - 15

Datasets

Release 1.2